MEMRI was then conducted immediately after intravenous injection of the solution, using a 400 MHz Bruker AVANCE III 9.4T wide-bore nuclear magnetic resonance spectrometer (Bruker, Germany) operated by ...

In other recent news, Bruker Corporation has reported its first-quarter 2025 earnings, surpassing analyst expectations with an earnings per share (EPS) of $0.47 compared to the forecast of $0.42.

Building on the success of its 1.0-1.2 GHz systems, Bruker's 1.3 GHz NMR spectrometer offers unprecedented resolution and sensitivity, enabling scientists to study complex biomolecular systems and ...

Frank Laukien, President and CEO, reported that Bruker achieved Q4 2024 constant exchange rate (CER) revenue growth of 15.8%, with reported revenues reaching $979.6 million and organic growth of 3.9%.

The group also has access to two 400 MHz instruments (one a Varian VNMRS, the other a second Bruker Avance III) operated by the Solid-State NMR Service. We also have access to other instruments via ...

Bruker put forward the winning bid for NanoString’s portfolio this past April, outdoing Patient Square Capital’s offer by paying about $392.6 million through a Chapter 11 auction.

Bruker is a very innovative, entrepreneurial company, and that’s why we felt it is a good home for the NanoString assets. When we acquired Canopy, which didn’t even have an instrument, we ...

Other Recent Developments by Bruker In August, Bruker completed the installation and acceptance of a 1.2 GHz Avance NMR spectrometer at the Korea Basic Science Institute (“KBSI”).

While the Monitor III are indeed excellent for Rock and Metal, they’re also pretty good performers for Pop, R&B, Jazz, and even classical.

Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI) Published Aug 13, 2024 1:35pm EDT ...